Skip to content

Blood Collection of Patient Presenting in the ED and Prescribed a BNP

A Blood Collection From Patients Presenting in the Emergency Department and Prescribed a Brain Natriuretic Peptide (BNP) Laboratory Test

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02614209
Acronym
BNP
Enrollment
400
Registered
2015-11-25
Start date
2015-05-31
Completion date
2016-08-31
Last updated
2016-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Keywords

ED, BNP

Brief summary

Plasma specimen collected from patients presenting in the Emergency Department (ED) with or without Heart Failure (HF) and prescribed a BNP.

Detailed description

Plasma samples are collected from a minimum of 400 subjects. Specimens are used to confirm the currently accepted BNP cut off as and aid in the diagnosis and assessment of HF. Stored specimens for future use in BNP assay development.

Interventions

DEVICEIn Vitro diagnostic tests

Prospective blood collection

Sponsors

Fujirebio Diagnostics, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females \>21 years of age * Able to understand and willing to provide informed consent * Present in to ED * BNP test requested

Exclusion criteria

* Males and females\< 21 years * Unable to provide informed consent * Not presenting to ED * hemolyzed sample

Design outcomes

Primary

MeasureTime frameDescription
Measure BNP6 months400 subjects

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026